​

Sanofi (SNY) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SNY Stock Forecast

Sanofi (SNY) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $64.00, with a high of $64.00 and a low of $64.00. This represents a 22.72% increase from the last price of $52.15.

$45 $49 $53 $57 $61 $65 High: $64 Avg: $64 Low: $64 Last Closed Price: $52.15

SNY Stock Rating

Sanofi stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (85.71%), 0 Hold (0.00%), 1 Sell (14.29%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 0 6 Strong Sell Sell Hold Buy Strong Buy

SNY Forecast vs Benchmarks

TypeNameUpside
StockSanofi22.72%
SectorHealthcare Stocks 25.20%
IndustryDrug Manufacturers - General Stocks22.62%

Price Target Trends

1M3M12M
# Anlaysts--3
Avg Price Target--$59.67
Last Closing Price$52.15$52.15$52.15
Upside/Downside--14.42%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25251--8
Dec, 24251--8
Nov, 24251--8
Oct, 24351--9
Sep, 24351--9
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 10, 2024Luisa HectorBerenberg Bank$64.00$58.519.38%22.72%
Jul 26, 2024Jasper HellwegArgus Research$60.00$52.5414.20%15.05%
Apr 03, 2024Jasper HellwegArgus Research$55.00$48.0014.58%5.47%
Dec 21, 2022Iain SimpsonBarclays$48.07$48.17-0.21%-7.82%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Oct 10, 2024Deutsche BankSellSellhold
Sep 23, 2024BarclaysOverweightOverweighthold
Sep 17, 2024CitigroupBuyBuyhold
Jul 29, 2024Deutsche BankSellSellhold
Jul 11, 2024GuggenheimBuyBuyhold
Jul 02, 2024JefferiesBuyBuyhold
Aug 18, 2022OppenheimerOutperformOutperformhold
Aug 12, 2022Deutsche BankHoldupgrade
Jun 07, 2022UBSBuyBuyhold

Financial Forecast

EPS Forecast

$2 $3 $4 $5 $6 $7 $8 $9 $10 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$9.81$4.97$6.69$4.31-----
Avg Forecast$2.85$3.22$4.10$4.01$3.69$4.14$4.56$4.94$5.44
High Forecast$2.68$3.03$3.75$3.94$3.43$3.91$4.19$4.55$5.01
Low Forecast$2.99$3.37$4.44$4.16$4.07$4.49$5.06$5.49$6.05
Surprise %244.21%54.35%63.17%7.48%-----

Revenue Forecast

$35B $41B $47B $53B $59B $65B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$37.37B$39.17B$45.39B$43.07B-----
Avg Forecast$44.64B$43.79B$47.74B$48.99B$45.48B$48.21B$51.82B$53.99B$56.14B
High Forecast$42.66B$41.85B$44.58B$47.09B$44.08B$46.77B$48.64B$50.68B$52.69B
Low Forecast$46.32B$45.44B$50.81B$50.55B$46.93B$50.33B$56.26B$58.61B$60.94B
Surprise %-16.30%-10.55%-4.92%-12.08%-----

Net Income Forecast

$4B $6B $7B $9B $11B $13B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$12.29B$6.22B$8.37B$5.40B-----
Avg Forecast$7.16B$8.09B$6.46B$7.10B$4.63B$5.20B$5.72B$6.21B$6.83B
High Forecast$6.74B$7.62B$5.16B$5.68B$4.31B$4.91B$5.27B$5.71B$6.29B
Low Forecast$7.50B$8.48B$7.75B$8.52B$5.11B$5.64B$6.36B$6.90B$7.60B
Surprise %71.79%-23.03%29.66%-23.96%-----

SNY Forecast FAQ

Is Sanofi stock a buy?

Sanofi stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 0 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Sanofi is a favorable investment for most analysts.

What is Sanofi's price target?

Sanofi's price target, set by 7 Wall Street analysts, averages $64 over the next 12 months. The price target range spans from $64 at the low end to $64 at the high end, suggesting a potential 22.72% change from the previous close price of $52.15.

How does Sanofi stock forecast compare to the average forecast of its sector, industry, and investment themes?

Sanofi stock forecast shows a 22.72% upside, underperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the drug manufacturers - general stocks industry (22.62%).

What is the breakdown of analyst ratings for Sanofi over the past three months?

  • January 2025: 25.00% Strong Buy, 62.50% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 25.00% Strong Buy, 62.50% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 25.00% Strong Buy, 62.50% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.

What is Sanofi’s EPS forecast?

Sanofi's average annual EPS forecast for its fiscal year ending in December is 3.69 for 2024, a -14.39% decrease from the reported $4.31 in 2023. The prediction for 2025 is $4.14, $4.56 for 2026, $4.94 for 2027, and $5.44 for 2028.

What is Sanofi’s revenue forecast?

Sanofi's average annual revenue forecast for its fiscal year ending in December is $45.48B for 2024, a 5.60% increase from the reported $43.07B in 2023. The forecast for 2025 is $48.21B, $51.82B for 2026, $53.99B for 2027, and $56.14B for 2028.

What is Sanofi’s net income forecast?

For its fiscal year ending in December, Sanofi's average annual net income forecast is $4.63B for 2024, reflecting a -14.22% decrease from the reported $5.4B in 2023. The projection for 2025 is $5.2B, $5.72B for 2026, $6.21B for 2027, and $6.83B for 2028.